Abstract
In a patient undergoing allogeneic BMT for ALL, chronic GVHD (cGVHD) with skin changes developed within 110 days after transplantation. One year post-BMT, anti-nuclear antibodies were detected. The patient’s serum was used for immunoscreening of a HeLa cDNA library. Ten different overlapping positive clones were found to be partial clones of mitosin, a 350-kDa nuclear phosphoprotein which shows a speckled nuclear distribution in S phase and which relocates to the centromere and mitotic apparatus in M phase. Although autoantibodies against centromere protein-F, which is very similar to mitosin, have been reported in patients with cancer, this is the first report of autoantibodies against mitosin in a patient with cGVHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muro, Y., Kamimoto, T. & Hagiwara, M. Anti-mitosin antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 19, 951–953 (1997). https://doi.org/10.1038/sj.bmt.1700764
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/sj.bmt.1700764
Keywords
This article is cited by
-
Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay
Molecular Cancer (2013)
-
Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT
Bone Marrow Transplantation (2001)


